Clinical impacts of copy number variations in B-cell differentiation and cell cycle control genes in pediatric B-cell acute lymphoblastic leukemia: a single centre experience

被引:8
作者
Crepinsek, Klementina [1 ,2 ]
Marinsek, Gasper [1 ]
Kavcic, Marko [2 ,3 ]
Prelog, Tomaz [3 ]
Kitanovski, Lidija [3 ]
Jazbec, Janez [2 ,3 ]
Debeljak, Marusa [1 ,2 ]
机构
[1] Univ Med Ctr Ljubljana, Univ Childrens Hosp, Clin Inst Special Lab Diagnost, Vrazov Trg 1, Ljubljana 1000, Slovenia
[2] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
[3] Univ Med Ctr Ljubljana, Univ Childrens Hosp, Dept Oncol & Haematol, Ljubljana, Slovenia
关键词
B-acute lymphoblastic leukemia; IKZF1; deletions; IKZF1(plus); MLPA; pediatric; copy number variations (CNVs); IKZF1; DELETION; IKAROS GENE; PROGNOSTIC MARKER; POOR-PROGNOSIS; PRECURSOR; CHILDHOOD; CHILDREN; PAX5; STRATIFICATION; CLASSIFICATION;
D O I
10.2478/raon-2021-0050
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background IKZF1 gene deletions have been identified as a poor prognostic factor in pediatric B-cell acute lymphoblastic leukemia (B-ALL), especially in the presence of co-occurring deletions (IKZF1(plus) profile). This study aimed to determine the frequency of IKZF1 deletions and deletions in other B-cell differentiation and cell cycle control genes, and their prognostic impact in Slovenian pediatric B-ALL patients. Patients and methods We studied a cohort of 99 patients diagnosed with B-ALL from January 2012 to December 2020 and treated according to the ALL IC-BFM 2009 protocol. Eighty-eight bone marrow or peripheral blood samples were analysed for copy number variations (CNVs) using the SALSA MLPA P335 ALL-IKZF1 probemix. Results At least one CNV was detected in more than 65% of analysed samples. The most frequently altered genes were PAX5 and CDKN2A/B (30.7%, 26.1%, and 25.0%, respectively). Deletions in IKZF1 were present in 18.2% of analysed samples and were associated with an inferior 5-year event-free survival (EFS; 54.8% vs. 85.9%, p = 0.016). The IKZF1(plus) profile was identified in 12.5% of the analysed samples, and these patients had an inferior 5-year EFS than those with deletions in IKZF1 only and those without deletions (50.8% vs. 75.0% vs. 85.9%, respectively, p = 0.049). Overall survival (OS) was also worse in patients with the IKZF1(plus) profile than those with deletions in IKZF1 only and those without deletions (5-year OS 76.2% vs. 100% vs. 93.0%, respectively). However, the difference between the groups was not statistically significant. Conclusions Our results are in concordance with the results obtained in larger cooperative clinical trials. Copy number variations analysis using the SALSA MLPA kit is a reliable tool for initial diagnostic approach in children with B-ALL, even in smaller institutions in low- and middle-income countries.
引用
收藏
页码:92 / 101
页数:10
相关论文
共 50 条
  • [21] IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan
    Asai, Daisuke
    Imamura, Toshihiko
    Suenobu, So-ichi
    Saito, Akiko
    Hasegawa, Daiichiro
    Deguchi, Takao
    Hashii, Yoshiko
    Matsumoto, Kimikazu
    Kawasaki, Hirohide
    Hori, Hiroki
    Iguchi, Akihiro
    Kosaka, Yoshiyuki
    Kato, Koji
    Horibe, Keizo
    Yumura-Yagi, Keiko
    Hara, Junichi
    Oda, Megumi
    CANCER MEDICINE, 2013, 2 (03): : 412 - 419
  • [22] Overview on Aneuploidy in Childhood B-Cell Acute Lymphoblastic Leukemia
    Panuciak, Kinga
    Nowicka, Emilia
    Mastalerczyk, Angelika
    Zawitkowska, Joanna
    Niedzwiecki, Maciej
    Lejman, Monika
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [23] Multiorgan Histiocytosis After B-Cell Acute Lymphoblastic Leukemia
    Pastor-Jane, Laia
    Escoda-Teigell, Lourdes
    Martinez-Gonzalez, Salome
    Turegano-Fuentes, Pilar
    Requena-Caballero, Luis
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2011, 33 (05) : 516 - 520
  • [24] Prognostic significance and treatment strategies for IKZF1 deletion in pediatric B-cell precursor acute lymphoblastic leukemia
    Pan, Lili
    Chen, Yiqiao
    Weng, Kaizhi
    Guo, Biyun
    Zhuang, Shuquan
    Huang, Shuxian
    Lian, Zhulan
    Wang, Xiaofang
    Li, Nainong
    Zheng, Yongzhi
    BMC CANCER, 2024, 24 (01)
  • [25] Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children
    Lejman, Monika
    Chalupnik, Aleksandra
    Chilimoniuk, Zuzanna
    Dobosz, Maciej
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [26] Immunophenotypic Characterization of Cytogenetic Subgroups in Egyptian Pediatric Patients With B-Cell Acute Lymphoblastic Leukemia
    Awad, Shady Adnan
    Kamel, Mahmoud M.
    Ayoub, Mahmoud A.
    Kamel, Ahmed M.
    Elnoshokaty, Essam H.
    El Hifnawi, Niveen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 : S19 - S24
  • [27] Individualized leukemia cell-population profiles in common B-cell acute lymphoblastic leukemia patients
    Yu, Jian-Hua
    Dong, Jing-Tao
    Jia, Yong-Qian
    Jiang, Neng-Gang
    Zeng, Ting-Ting
    Xu, Hong
    Mo, Xian-Ming
    Meng, Wen-Tong
    CHINESE JOURNAL OF CANCER, 2013, 32 (04) : 213 - 223
  • [28] CD33+ B-CELL PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN - A DISTINCT SUBGROUP OF B-CELL PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA
    HARA, J
    HOSOI, G
    OKAMURA, T
    OSUGI, Y
    ISHIHARA, S
    YUMURAYAGI, K
    KAWAHA, K
    TAWA, A
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1995, 61 (02) : 77 - 84
  • [29] Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms
    Ribera, Jordi
    Zamora, Lurdes
    Morgades, Mireia
    Mallo, Mar
    Solanes, Neus
    Batlle, Montserrat
    Vives, Susana
    Granada, Isabel
    Junca, Jordi
    Malinverni, Roberto
    Genesca, Eulalia
    Guardia, Ramon
    Mercadal, Santiago
    Escoda, Lourdes
    Martinez-Lopez, Joaquin
    Tormo, Mar
    Esteve, Jordi
    Pratcorona, Marta
    Martinez-Losada, Carmen
    Sole, Francesc
    Feliu, Evarist
    Ribera, Josep-Maria
    GENES CHROMOSOMES & CANCER, 2017, 56 (11) : 810 - 820
  • [30] Cobalamin deficiency during treatment of pediatric precursor B-cell acute lymphoblastic leukemia
    Kinoshita, Hiromi
    Watanabe, Atsuko
    Taji, Yoshitada
    Yoshimura, Moe
    Ohta, Atsuhiko
    Fukushima, Takashi
    Tanaka, Ryuhei
    Ebihara, Yasuhiro
    PEDIATRIC BLOOD & CANCER, 2021, 68 (12)